Itron director granted 248 common shares

LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

LEYDEN TIMOTHY M reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Timothy M. Leyden received a grant of 248 shares of common stock as part of regular quarterly compensation for independent board members. The shares were awarded at no cash cost. Following this grant, he directly holds 16,253 common shares.

The filing notes that Mr. Leyden deferred receipt of 93 of the granted shares under Itron's Executive Deferred Compensation Plan, so only the remaining portion is received immediately while the deferred shares will be credited according to that plan's terms.

Insider Trade Summary

Grant/Award: 248 shares

Grant/Award 1 txn

Insider LEYDEN TIMOTHY M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	248	$0.00	$0.00

Holdings After Transaction: Common Stock — 16,253 shares (Direct)

Footnotes (1)

1. F1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 93 shares pursuant to Itron's Executive Deferred Compensation Plan.

Key Figures

Stock grant size: 248 shares Grant price per share: $0.00 per share Shares held after grant: 16,253 shares +1 more

4 metrics

Stock grant size 248 shares Quarterly common stock grant to independent director

Grant price per share $0.00 per share Equity compensation, non-cash award

Shares held after grant 16,253 shares Total direct Itron common stock held by Timothy M. Leyden

Deferred shares from grant 93 shares Portion of award deferred under Executive Deferred Compensation Plan

Key Terms

grant of common stock, annual compensation for board service, Executive Deferred Compensation Plan, Form 4

4 terms

grant of common stock financial

"Reflects the grant of common stock independent members of Itron's board of directors receive quarterly"

annual compensation for board service financial

"receive quarterly as part of their annual compensation for board service"

Executive Deferred Compensation Plan financial

"Mr. Leyden deferred receipt of 93 shares pursuant to Itron's Executive Deferred Compensation Plan"

Form 4 regulatory

"The transaction is reported on Form 4 as a grant or award acquisition"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Itron (ITRI) director Timothy Leyden report?

Timothy M. Leyden reported receiving a grant of 248 Itron common shares as part of his quarterly board compensation. This is a non-cash equity award, typical for independent directors, and reflects routine compensation rather than an open-market stock purchase or sale.

How many Itron (ITRI) shares does Timothy Leyden hold after this Form 4?

After the reported grant, Timothy M. Leyden directly holds 16,253 Itron common shares. This total includes the newly awarded stock, showing his ongoing equity stake as an independent director following the routine quarterly compensation grant reported in this Form 4.

Was cash paid for the Itron (ITRI) shares granted to Timothy Leyden?

No cash was paid for these shares. The 248 Itron common shares were granted at a price of $0.00 per share as part of Mr. Leyden’s annual board compensation, reflecting a standard stock-based award rather than a market transaction involving purchase funds.

Did Timothy Leyden defer any of his Itron (ITRI) stock award?

Yes. Of the 248 Itron common shares granted, Timothy M. Leyden deferred receipt of 93 shares under Itron's Executive Deferred Compensation Plan. The remaining shares are received immediately, while deferred shares follow the plan’s distribution rules for future delivery.

Is the Itron (ITRI) Form 4 for Timothy Leyden a buy or a grant?

The transaction is a grant, not an open-market buy. The Form 4 shows an "A" code, meaning a grant or award acquisition of 248 common shares, provided as equity compensation to Timothy M. Leyden for his service as an independent member of Itron’s board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 02:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEYDEN TIMOTHY M

(Last) (First) (Middle)

2111 N. MOLTER ROAD

(Street)

LIBERTY LAKE WASHINGTON 99019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		248(1)	A	$0	16,253	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. Mr. Leyden deferred receipt of 93 shares pursuant to Itron's Executive Deferred Compensation Plan.

	/s/ Christopher E. Ware, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)